Author:
Manickam Alagar,Sivanandham Muthukumaran,Tourkova Irina L.
Reference42 articles.
1. Adams, M., Borysiewicz, L., Fiander, A., Man, S., Jasani, B., Navabi, H., Lipetz, C., Evans, A. S. and Mason, M. (2001) Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine 19, 2549–2556.
2. Adams, M., Navabi, H., Jasani, B., Man, S., Fiander, A., Evans, A. S., Donninger, C. and Mason, M. (2003) Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R). Vaccine 21, 787–790.
3. Aiba, S. and Katz, S. I. (1990) Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunol. 145, 2791–2796.
4. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811.
5. Barberis, M. C., Vago, L., Cecchini, G., Bramerio, M., Banfi, G., D’Amico, M. and Cannone, M. (1998) Local impairment of immunoreactivity in HIV-infected women with HPV-related squamous intraepithelial lesions of the cervix. Tumori 84, 489–492.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献